Last $8.42 USD
Change Today -0.16 / -1.86%
Volume 37.4K
As of 8:10 PM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).

medical action ind inc (MDCI) Snapshot

Open
$8.60
Previous Close
$8.58
Day High
$8.60
Day Low
$8.39
52 Week High
05/8/13 - $8.99
52 Week Low
11/16/12 - $2.25
Market Cap
138.0M
Average Volume 10 Days
48.7K
EPS TTM
$-0.06
Shares Outstanding
16.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDICAL ACTION IND INC (MDCI)

Related News

No related news articles were found.

medical action ind inc (MDCI) Related Businessweek News

No Related Businessweek News Found

medical action ind inc (MDCI) Details

Medical Action Industries Inc. develops, manufactures, markets, and supplies various disposable medical products primarily in the United States and Canada. Its products include custom procedure trays; minor procedure kits and trays; operating room disposables and sterilization products; dressings and surgical sponges; patient bedside products; containment systems for medical waste; and laboratory products. The company also manufactures its products under private label programs to other distributors and medical suppliers. Medical Action Industries Inc. markets and sells its products primarily to acute care facilities through its direct sales personnel and a network of health care distributors, as well as to end-user markets, including physician, dental, and veterinary offices; outpatient surgery centers; and long-term care facilities and laboratories. The company was founded in 1977 and is headquartered in Brentwood, New York.

1,210 Employees
Last Reported Date: 06/14/12
Founded in 1977

medical action ind inc (MDCI) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $550.8K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $10.6K
President of Custom Procedure Trays & Operati...
Total Annual Compensation: $420.2K
President of Patient Care Products and Genera...
Total Annual Compensation: $350.0K
Vice President of Operations & Business Devel...
Total Annual Compensation: $325.0K
Compensation as of Fiscal Year 2012.

medical action ind inc (MDCI) Key Developments

Medical Action Industries Inc. Announces Unaudited Consolidated Financial Results for the Third Quarter and Nine Months Ended December 31, 2012; Reports Goodwill Impairment Charge for the Quarter Ended December 31, 2012

Medical Action Industries Inc. announced unaudited consolidated financial results for the third quarter and nine months ended December 31, 2012. For the quarter, the company reported net sales of $109.4 million against $113.0 million a year ago. Operating loss was $75.4 million against operating income of $3.8 million a year ago. Loss before income taxes and extraordinary item was $76.6 million or $3.39 per diluted share against income before income taxes and extraordinary item of $2.6 million or $0.11 per diluted share a year ago. Net loss was $55.5 million or $3.39 per basic and diluted share against net income of $1.8 million or $0.11 per basic and diluted share a year ago. Non-GAAP net income was $1.6 million or $0.10 per diluted share against nil a years ago. EBITDA, as adjusted was $6.1 million against $3.8 million a year ago. LBITDA was $73.2 million as compared to EBITDA of $6.3 million for the same period prior year. This decrease in net sales is the result in part from management's efforts to focus on profitable business and to decrease or eliminate unprofitable or non-core sales. For the nine months, the company reported net sales of $333.7 million against $329.1 million a year ago. Operating loss was $73.1 million against operating income of $6.7 million a year ago. Loss before income taxes and extraordinary item was $76.7 million or $3.39 per diluted share against income before income taxes and extraordinary item of $3.3 million or $0.13 per diluted share a year ago. Net loss was $55.6 million or $3.39 per diluted share against net income of $2.6 million or $0.16 per diluted share a year ago. Non-GAAP net income was $2 million or $0.120 per diluted share against $0.4 million or $0.03 per diluted share a year ago. EBITDA, as adjusted was $14.1 million against $12.5 million a year ago. LBITDA was $66.4 million as compared to EBITDA of $15.1 million for the same period prior year. During the nine months ended December 31, 2012, the company generated $17.5 million in cash from operations. For the fourth quarter of 2012, the company reported goodwill impairment charge of $78.6 million.

Medical Action Industries Inc., Q3 2013 Earnings Call, Feb 11, 2013

Medical Action Industries Inc., Q3 2013 Earnings Call, Feb 11, 2013

Medical Action Industries Inc. to Report Q3, 2013 Results on Feb 11, 2013

Medical Action Industries Inc. announced that they will report Q3, 2013 results at 9:00 AM, Eastern Standard Time on Feb 11, 2013

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDCI:US $8.42 USD -0.16

MDCI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ansell Ltd A$16.32 AUD -0.34
Becton Dickinson and Co $101.78 USD +1.28
Derma Sciences Inc $14.29 USD -0.06
Getinge AB kr199.80 SEK -1.30
Teleflex Inc $80.42 USD -0.18
View Industry Companies
 

Industry Analysis

MDCI

Industry Average

Valuation MDCI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book 1.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.2x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICAL ACTION IND INC, please visit www.medical-action.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.